Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A novel mutation of the C-terminal amino acid of FUS (Y526C) strengthens FUS gene as the most frequent genetic factor in aggressive juvenile ALS.
Corcia P, Danel V, Lacour A, Beltran S, Andres C, Couratier P, Blasco H, Vourc'h P. Corcia P, et al. Among authors: lacour a. Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):298-301. doi: 10.1080/21678421.2016.1265564. Epub 2017 Jan 5. Amyotroph Lateral Scler Frontotemporal Degener. 2017. PMID: 28054830
Home care organization impacts patient management and survival in ALS.
Lavernhe S, Antoine JC, Court-Fortune I, Dimier N, Costes F, Lacour A, Camdessanché JP. Lavernhe S, et al. Among authors: lacour a. Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):562-568. doi: 10.1080/21678421.2017.1332076. Epub 2017 Jun 6. Amyotroph Lateral Scler Frontotemporal Degener. 2017. PMID: 28585472
Real-life effectiveness 1 year after switching to avalglucosidase alfa in late-onset Pompe disease patients worsening on alglucosidase alfa therapy: A French cohort study.
Tard C, Bouhour F, Michaud M, Beltran S, Fournier M, Demurger F, Lagrange E, Nollet S, Sacconi S, Noury JB, Magot A, Cintas P, Renard D, Deibener-Kaminsky J, Lefeuvre C, Davion JB, Salort-Campana E, Arrassi A, Taouagh N, Spinazzi M; Pompe Study Group; Attarian S, Laforêt P. Tard C, et al. Eur J Neurol. 2024 Jul;31(7):e16292. doi: 10.1111/ene.16292. Epub 2024 Apr 8. Eur J Neurol. 2024. PMID: 38587143 Free PMC article.
Genotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France.
Mariani LL, Lozeron P, Théaudin M, Mincheva Z, Signate A, Ducot B, Algalarrondo V, Denier C, Adam C, Nicolas G, Samuel D, Slama MS, Lacroix C, Misrahi M, Adams D; French Familial Amyloid Polyneuropathies Network (CORNAMYL) Study Group. Mariani LL, et al. Ann Neurol. 2015 Dec;78(6):901-16. doi: 10.1002/ana.24519. Epub 2015 Oct 7. Ann Neurol. 2015. PMID: 26369527 Free PMC article.
Characteristics of Patients With Late-Onset Pompe Disease in France: Insights From the French Pompe Registry in 2022.
Lefeuvre C, De Antonio M, Bouhour F, Tard C, Salort-Campana E, Lagrange E, Behin A, Sole G, Noury JB, Sacconi S, Magot A, Nadaj-Pakleza A, Lacour A, Beltran S, Spinazzi M, Cintas P, Renard D, Michaud M, Bedat-Millet AL, Prigent H, Taouagh N, Arrassi A, Hamroun D, Attarian S, Laforêt P; for Pompe Study Group. Lefeuvre C, et al. Among authors: lacour a. Neurology. 2023 Aug 29;101(9):e966-e977. doi: 10.1212/WNL.0000000000207547. Epub 2023 Jul 7. Neurology. 2023. PMID: 37419682 Free PMC article.
Confounding clinical presentation and different disease progression in CMT4B1.
Guimarães-Costa R, Villar-Quiles RN, Latour P, Sole G, Husson I, Lacour A, Leonard-Louis S, Stojkovic T. Guimarães-Costa R, et al. Among authors: lacour a. Neuromuscul Disord. 2020 Jul;30(7):576-582. doi: 10.1016/j.nmd.2020.05.003. Epub 2020 May 16. Neuromuscul Disord. 2020. PMID: 32586600
[Respiratory failure due to acid maltase deficiency].
Perez T, Marié E, Lacour A, Maurage CA, Wallaert B. Perez T, et al. Among authors: lacour a. Rev Mal Respir. 2012 Jan;29(1):74-8. doi: 10.1016/j.rmr.2011.10.008. Epub 2011 Nov 25. Rev Mal Respir. 2012. PMID: 22240224 French.
148 results